• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2022

    3/10/22 10:02:38 AM ET
    $AMR
    $ANET
    $ASAN
    $AVA
    Coal Mining
    Energy
    Computer Communications Equipment
    Telecommunications
    Get the next $AMR alert in real time by email

     

    Upgrades

    • For Alpha Metallurgical Resources Inc (NYSE:AMR), B. Riley Securities upgraded the previous rating of Neutral to Buy. For the fourth quarter, Alpha Metallurgical had an EPS of $13.30, compared to year-ago quarter EPS of $3.00. At the moment, the stock has a 52-week-high of $132.70 and a 52-week-low of $11.13. Alpha Metallurgical closed at $121.64 at the end of the last trading period.
    • For Hormel Foods Corp (NYSE:HRL), Argus Research upgraded the previous rating of Hold to Buy. In the first quarter, Hormel Foods showed an EPS of $0.44, compared to $0.41 from the year-ago quarter. The stock has a 52-week-high of $53.19 and a 52-week-low of $40.48. At the end of the last trading period, Hormel Foods closed at $49.91.
    • According to Wells Fargo, the prior rating for Arista Networks Inc (NYSE:ANET) was changed from Equal-Weight to Overweight. In the fourth quarter, Arista Networks showed an EPS of $0.82, compared to $0.62 from the year-ago quarter. At the moment, the stock has a 52-week-high of $536.54 and a 52-week-low of $108.23. Arista Networks closed at $120.61 at the end of the last trading period.
    • According to Stifel, the prior rating for IDEAYA Biosciences Inc (NASDAQ:IDYA) was changed from Hold to Buy. In the third quarter, IDEAYA Biosciences showed an EPS of $0.31, compared to $0.17 from the year-ago quarter. The current stock performance of IDEAYA Biosciences shows a 52-week-high of $28.00 and a 52-week-low of $11.75. Moreover, at the end of the last trading period, the closing price was at $12.79.
    • According to Barclays, the prior rating for NetApp Inc (NASDAQ:NTAP) was changed from Equal-Weight to Overweight. In the third quarter, NetApp showed an EPS of $1.44, compared to $1.10 from the year-ago quarter. The current stock performance of NetApp shows a 52-week-high of $96.82 and a 52-week-low of $63.23. Moreover, at the end of the last trading period, the closing price was at $80.78.
    • JP Morgan upgraded the previous rating for Toll Brothers Inc (NYSE:TOL) from Underweight to Neutral. Toll Brothers earned $1.24 in the first quarter, compared to $0.76 in the year-ago quarter. The current stock performance of Toll Brothers shows a 52-week-high of $75.61 and a 52-week-low of $47.17. Moreover, at the end of the last trading period, the closing price was at $51.60.
    • For Pilgrims Pride Corp (NASDAQ:PPC), BMO Capital upgraded the previous rating of Market Perform to Outperform. Pilgrims Pride earned $0.56 in the fourth quarter, compared to $0.25 in the year-ago quarter. At the moment, the stock has a 52-week-high of $29.70 and a 52-week-low of $20.23. Pilgrims Pride closed at $22.96 at the end of the last trading period.
    • According to JP Morgan, the prior rating for KB Home (NYSE:KBH) was changed from Neutral to Overweight. For the fourth quarter, KB Home had an EPS of $1.91, compared to year-ago quarter EPS of $1.12. The stock has a 52-week-high of $52.48 and a 52-week-low of $33.94. At the end of the last trading period, KB Home closed at $38.10.
    • According to BTIG, the prior rating for CrowdStrike Holdings Inc (NASDAQ:CRWD) was changed from Neutral to Buy. For the fourth quarter, CrowdStrike Holdings had an EPS of $0.30, compared to year-ago quarter EPS of $0.13. The stock has a 52-week-high of $298.48 and a 52-week-low of $150.02. At the end of the last trading period, CrowdStrike Holdings closed at $169.79.

    See all analyst ratings upgrades.

     

    Downgrades

    • Wolfe Research downgraded the previous rating for Newmark Group Inc (NASDAQ:NMRK) from Outperform to Peer Perform. In the fourth quarter, Newmark Group showed an EPS of $0.65, compared to $0.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $19.10 and a 52-week-low of $9.88. Newmark Group closed at $16.57 at the end of the last trading period.
    • Craig-Hallum downgraded the previous rating for Kirkland's Inc (NASDAQ:KIRK) from Buy to Hold. Kirkland's earned $0.51 in the third quarter, compared to $0.66 in the year-ago quarter. The current stock performance of Kirkland's shows a 52-week-high of $34.45 and a 52-week-low of $12.50. Moreover, at the end of the last trading period, the closing price was at $13.79.
    • Northcoast Research downgraded the previous rating for McDonald's Corp (NYSE:MCD) from Buy to Neutral. McDonald's earned $2.23 in the fourth quarter, compared to $1.70 in the year-ago quarter. The current stock performance of McDonald's shows a 52-week-high of $271.15 and a 52-week-low of $208.24. Moreover, at the end of the last trading period, the closing price was at $222.47.
    • Piper Sandler downgraded the previous rating for Coterra Energy Inc (NYSE:CTRA) from Overweight to Neutral. At the moment, the stock has a 52-week-high of $27.93 and a 52-week-low of $14.28. Coterra Energy closed at $25.46 at the end of the last trading period.
    • According to Wells Fargo, the prior rating for Cisco Systems Inc (NASDAQ:CSCO) was changed from Overweight to Equal-Weight. In the second quarter, Cisco Systems showed an EPS of $0.84, compared to $0.79 from the year-ago quarter. The stock has a 52-week-high of $64.28 and a 52-week-low of $47.72. At the end of the last trading period, Cisco Systems closed at $55.92.
    • Wells Fargo downgraded the previous rating for Hess Midstream LP (NYSE:HESM) from Overweight to Equal-Weight. For the fourth quarter, Hess Midstream had an EPS of $0.51, compared to year-ago quarter EPS of $0.36. The stock has a 52-week-high of $35.71 and a 52-week-low of $20.36. At the end of the last trading period, Hess Midstream closed at $31.90.
    • For Mettler-Toledo International Inc (NYSE:MTD), Goldman Sachs downgraded the previous rating of Neutral to Sell. For the fourth quarter, Mettler-Toledo Intl had an EPS of $10.53, compared to year-ago quarter EPS of $9.26. The stock has a 52-week-high of $1714.75 and a 52-week-low of $1049.20. At the end of the last trading period, Mettler-Toledo Intl closed at $1388.29.
    • Cowen & Co. downgraded the previous rating for Renewable Energy Group Inc (NASDAQ:REGI) from Outperform to Market Perform. Renewable Energy Gr earned $1.03 in the fourth quarter, compared to $0.60 in the year-ago quarter. The stock has a 52-week-high of $85.22 and a 52-week-low of $32.54. At the end of the last trading period, Renewable Energy Gr closed at $60.97.
    • For Meritage Homes Corp (NYSE:MTH), JP Morgan downgraded the previous rating of Overweight to Neutral. Meritage Homes earned $6.25 in the fourth quarter, compared to $3.97 in the year-ago quarter. At the moment, the stock has a 52-week-high of $125.01 and a 52-week-low of $84.05. Meritage Homes closed at $96.52 at the end of the last trading period.
    • JP Morgan downgraded the previous rating for Green Brick Partners Inc (NYSE:GRBK) from Neutral to Underweight. In the fourth quarter, Green Brick Partners showed an EPS of $1.24, compared to $0.58 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.25 and a 52-week-low of $19.61. Green Brick Partners closed at $22.69 at the end of the last trading period.
    • According to JP Morgan, the prior rating for Asana Inc (NYSE:ASAN) was changed from Neutral to Underweight. In the fourth quarter, Asana showed an EPS of $0.25, compared to $0.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $145.79 and a 52-week-low of $25.41. Asana closed at $48.81 at the end of the last trading period.

    See all analyst ratings downgrades.

     

    Initiations

    • With a Buy rating, Roth Capital initiated coverage on iSun Inc (NASDAQ:ISUN). The price target seems to have been set at $7.00 for iSun. For the third quarter, iSun had an EPS of $0.12, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $18.28 and a 52-week-low of $4.26. At the end of the last trading period, iSun closed at $5.09.
    • With a Buy rating, DA Davidson initiated coverage on Shift4 Payments Inc (NYSE:FOUR). The price target seems to have been set at $70.00 for Shift4 Payments. In the fourth quarter, Shift4 Payments showed an EPS of $0.08, compared to $0.05 from the year-ago quarter. The current stock performance of Shift4 Payments shows a 52-week-high of $104.11 and a 52-week-low of $38.88. Moreover, at the end of the last trading period, the closing price was at $45.77.
    • With a Buy rating, Brookline Capital initiated coverage on Verrica Pharmaceuticals Inc (NASDAQ:VRCA). The price target seems to have been set at $20.00 for Verrica Pharmaceuticals. For the fourth quarter, Verrica Pharmaceuticals had an EPS of $0.35, compared to year-ago quarter EPS of $0.52. The current stock performance of Verrica Pharmaceuticals shows a 52-week-high of $18.42 and a 52-week-low of $7.10. Moreover, at the end of the last trading period, the closing price was at $7.96.
    • HC Wainwright & Co. initiated coverage on Esperion Therapeutics Inc (NASDAQ:ESPR) with a Buy rating. The price target for Esperion Therapeutics is set to $22.00. In the fourth quarter, Esperion Therapeutics showed an EPS of $1.77, compared to $3.89 from the year-ago quarter. The stock has a 52-week-high of $32.00 and a 52-week-low of $3.28. At the end of the last trading period, Esperion Therapeutics closed at $4.57.
    • Mizuho initiated coverage on Idacorp Inc (NYSE:IDA) with a Buy rating. The price target for Idacorp is set to $119.00. For the fourth quarter, Idacorp had an EPS of $0.65, compared to year-ago quarter EPS of $0.74. At the moment, the stock has a 52-week-high of $114.19 and a 52-week-low of $92.40. Idacorp closed at $108.95 at the end of the last trading period.
    • Mizuho initiated coverage on Avista Corp (NYSE:AVA) with a Neutral rating. The price target for Avista is set to $47.00. Avista earned $0.71 in the fourth quarter, compared to $0.85 in the year-ago quarter. The current stock performance of Avista shows a 52-week-high of $49.14 and a 52-week-low of $37.73. Moreover, at the end of the last trading period, the closing price was at $45.14.
    • With a Neutral rating, Mizuho initiated coverage on NorthWestern Corp (NASDAQ:NWE). The price target seems to have been set at $62.00 for NorthWestern. NorthWestern earned $1.04 in the fourth quarter, compared to $1.29 in the year-ago quarter. The stock has a 52-week-high of $70.80 and a 52-week-low of $53.66. At the end of the last trading period, NorthWestern closed at $60.97.
    • JP Morgan initiated coverage on C4 Therapeutics Inc (NASDAQ:CCCC) with an Overweight rating. The price target for C4 Therapeutics is set to $43.00. C4 Therapeutics earned $0.31 in the fourth quarter, compared to $3.45 in the year-ago quarter. The current stock performance of C4 Therapeutics shows a 52-week-high of $51.21 and a 52-week-low of $19.81. Moreover, at the end of the last trading period, the closing price was at $24.21.
    • JP Morgan initiated coverage on Kymera Therapeutics Inc (NASDAQ:KYMR) with a Neutral rating. The price target for Kymera Therapeutics is set to $44.00. In the fourth quarter, Kymera Therapeutics showed an EPS of $0.66, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $69.12 and a 52-week-low of $29.93. Kymera Therapeutics closed at $40.13 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $AMR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMR
    $ANET
    $ASAN
    $AVA

    CompanyDatePrice TargetRatingAnalyst
    Alpha Metallurgical Resources Inc.
    $AMR
    2/4/2026$203.00Buy → Neutral
    B. Riley Securities
    McDonald's Corporation
    $MCD
    2/2/2026$360.00Neutral → Buy
    BTIG Research
    Kymera Therapeutics Inc.
    $KYMR
    1/28/2026$133.00Overweight
    Barclays
    Cisco Systems Inc.
    $CSCO
    1/26/2026$100.00In-line → Outperform
    Evercore ISI
    NorthWestern Energy Group Inc.
    $NWE
    1/20/2026$53.00Equal Weight → Underweight
    Wells Fargo
    NetApp Inc.
    $NTAP
    1/20/2026$89.00Equal-Weight → Underweight
    Morgan Stanley
    IDACORP Inc.
    $IDA
    1/20/2026$118.00Equal Weight → Underweight
    Wells Fargo
    Meritage Homes Corporation
    $MTH
    1/16/2026$82.00Buy → Neutral
    BofA Securities
    More analyst ratings

    $AMR
    $ANET
    $ASAN
    $AVA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NorthWestern Energy Reports 2025 Financial Results

    2025 Diluted GAAP EPS of $2.94, compared to $3.65 in 2024. 2025 Adjusted Diluted Non-GAAP EPS of $3.58, compared to $3.40 in 2024. Affirms 4% to 6% long-term EPS growth rate. Announces 2026 earnings guidance range of $3.68 to $3.83 per diluted share. Increases quarterly dividend by 1.5% – to $0.67 per share – payable March 31, 2026. Announces $3.2 billion 5-year capital plan, a 17% increase over prior plan. NorthWestern Energy Group, Inc. d/b/a NorthWestern Energy (NASDAQ:NWE) reported financial results for the year ended December 31, 2025. Net income for the period was $181.1 million, or $2.94 per diluted share, as compared with net income of $224.1 million, or $3.65 per

    2/11/26 8:00:00 PM ET
    $NWE
    Power Generation
    Utilities

    Pilgrim's Pride Reports Fourth Quarter and Year-End 2025 Results

    GREELEY, Colo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Pilgrim's Pride Corporation (NASDAQ:PPC), one of the world's leading food companies, reports its fourth quarter and year-end 2025 financial results. 2025 Highlights Net Sales of $18.5 billion.Consolidated GAAP Operating Income margin of 8.7%.GAAP Net Income of $1.1 billion and GAAP EPS of $4.54. Adjusted Net Income of $1.2 billion, and Adjusted EPS of $5.17.Adjusted EBITDA of $2.3 billion, or a 12.3% margin, with Adjusted EBITDA margins of 14.8% in the U.S., 8.4% in Europe, and 8.8% in Mexico.Pilgrim's U.S. Fresh portfolio benefited from robust demand across retail and foodservice. Volume from Key Customers in both Case Ready and Small Bi

    2/11/26 4:44:23 PM ET
    $PPC
    Meat/Poultry/Fish
    Consumer Staples

    Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    ANN ARBOR, Mich., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that on February 10, 2026, the Company granted 11 new employees 40,200 restricted stock units (RSUs) under Esperion's 2017 Inducement Equity Incentive Plan. The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducement material to such individual's entering into employment with Esperion, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules. Each RSU will vest and become exercisable as to 25 percent of the shar

    2/11/26 4:30:00 PM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMR
    $ANET
    $ASAN
    $AVA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLETOL issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLETOL (SUPPL-13) with active ingredient BEMPEDOIC ACID has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211616, Application Classification: Efficacy

    3/25/24 4:41:29 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMR
    $ANET
    $ASAN
    $AVA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Courtis Kenneth S. bought $1,693,441 worth of shares (9,000 units at $188.16), increasing direct ownership by 1% to 816,537 units (SEC Form 4)

    4 - Alpha Metallurgical Resources, Inc. (0001704715) (Issuer)

    12/17/25 4:53:28 PM ET
    $AMR
    Coal Mining
    Energy

    Director Gorzynski Michael bought $7,271,494 worth of shares (38,576 units at $188.50) (SEC Form 4)

    4 - Alpha Metallurgical Resources, Inc. (0001704715) (Issuer)

    12/17/25 2:39:23 PM ET
    $AMR
    Coal Mining
    Energy

    Amendment: Director Courtis Kenneth S. bought $6,694,203 worth of shares (37,000 units at $180.92), increasing direct ownership by 5% to 807,537 units (SEC Form 4)

    4/A - Alpha Metallurgical Resources, Inc. (0001704715) (Issuer)

    12/16/25 6:44:01 PM ET
    $AMR
    Coal Mining
    Energy

    $AMR
    $ANET
    $ASAN
    $AVA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Global Sales Tuszik Oliver covered exercise/tax liability with 3,695 shares, decreasing direct ownership by 2% to 191,745 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    2/11/26 8:44:07 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    SVP & Chief Acctg Officer Wong Maria Victoria covered exercise/tax liability with 1,191 shares, decreasing direct ownership by 4% to 31,037 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    2/11/26 8:46:09 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    EVP, Operations Subaiya Thimaya K. covered exercise/tax liability with 6,736 shares, decreasing direct ownership by 4% to 170,386 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    2/11/26 8:43:28 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $AMR
    $ANET
    $ASAN
    $AVA
    SEC Filings

    View All

    Pilgrim's Pride Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - PILGRIMS PRIDE CORP (0000802481) (Filer)

    2/11/26 9:54:59 PM ET
    $PPC
    Meat/Poultry/Fish
    Consumer Staples

    Pilgrim's Pride Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - PILGRIMS PRIDE CORP (0000802481) (Filer)

    2/11/26 9:54:48 PM ET
    $PPC
    Meat/Poultry/Fish
    Consumer Staples

    SEC Form 424B3 filed by Bank Nova Scotia Halifax Pfd 3

    424B3 - BANK OF NOVA SCOTIA (0000009631) (Filer)

    2/11/26 5:18:16 PM ET
    $BNS
    Major Banks
    Finance

    $AMR
    $ANET
    $ASAN
    $AVA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alpha Metallurgical Resources downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded Alpha Metallurgical Resources from Buy to Neutral and set a new price target of $203.00

    2/4/26 8:27:05 AM ET
    $AMR
    Coal Mining
    Energy

    McDonald's upgraded by BTIG Research with a new price target

    BTIG Research upgraded McDonald's from Neutral to Buy and set a new price target of $360.00

    2/2/26 6:47:28 AM ET
    $MCD
    Restaurants
    Consumer Discretionary

    Barclays resumed coverage on Kymera Therapeutics with a new price target

    Barclays resumed coverage of Kymera Therapeutics with a rating of Overweight and set a new price target of $133.00

    1/28/26 7:18:07 AM ET
    $KYMR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMR
    $ANET
    $ASAN
    $AVA
    Financials

    Live finance-specific insights

    View All

    Pilgrim's Pride Reports Fourth Quarter and Year-End 2025 Results

    GREELEY, Colo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Pilgrim's Pride Corporation (NASDAQ:PPC), one of the world's leading food companies, reports its fourth quarter and year-end 2025 financial results. 2025 Highlights Net Sales of $18.5 billion.Consolidated GAAP Operating Income margin of 8.7%.GAAP Net Income of $1.1 billion and GAAP EPS of $4.54. Adjusted Net Income of $1.2 billion, and Adjusted EPS of $5.17.Adjusted EBITDA of $2.3 billion, or a 12.3% margin, with Adjusted EBITDA margins of 14.8% in the U.S., 8.4% in Europe, and 8.8% in Mexico.Pilgrim's U.S. Fresh portfolio benefited from robust demand across retail and foodservice. Volume from Key Customers in both Case Ready and Small Bi

    2/11/26 4:44:23 PM ET
    $PPC
    Meat/Poultry/Fish
    Consumer Staples

    CISCO REPORTS SECOND QUARTER EARNINGS

    SAN JOSE, Calif., Feb. 11, 2026 /PRNewswire/ --  News Summary: Double-digit top and bottom-line growth exceeding our guidance, with EPS growing faster than revenueRecord revenue of $15.3 billion, up 10% year over year; GAAP EPS of $0.80, up 31% year over year; and Non-GAAP EPS of $1.04, up 11% year over yearGAAP gross margin of 65.0% and Non-GAAP gross margin of 67.5%; GAAP operating margin of 24.6% and Non-GAAP operating margin of 34.6%, both above the high end of our guidance rangeAccelerating, double-digit growth in product orders across all geographies and robust growth ac

    2/11/26 4:05:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    McDONALD'S REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS

    Global comparable sales in the fourth quarter increased 5.7%, with positive global comparable guest counts and strong comparable sales growth across all segmentsGlobal Systemwide sales* for the full year increased 7% (5% in constant currencies) to over $139 billion, or growth of $9 billion ($7 billion in constant currencies)Across 70 loyalty markets, Systemwide sales to loyalty members for the full year increased 20% to nearly $37 billion, with 90-day active loyalty users up 19% to nearly 210 million as of year-endCHICAGO, Feb. 11, 2026 /PRNewswire/ -- McDonald's Corporation today announced results for the fourth quarter and year ended December 31, 2025. "McDonald's value leadership is work

    2/11/26 4:01:00 PM ET
    $MCD
    Restaurants
    Consumer Discretionary

    $AMR
    $ANET
    $ASAN
    $AVA
    Leadership Updates

    Live Leadership Updates

    View All

    Toll Brothers Announces New Luxury Home Community Coming Soon to Argyle, Texas

    ARGYLE, Texas, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest Dallas-area community, Toll Brothers at Furst Ranch, is coming soon to Argyle, Texas. This exclusive community will feature two collections of single-family homes on expansive 70- and 80-foot-wide home sites as well as access to an array of amenities within the 2,000-acre master plan. Site work is underway at Cross Timbers Road and SH 377 in Argyle, and the community is anticipated to open for sale in summer 2026. Toll Brothers at Furst Ranch will offer an array of contemporary home designs on oversized home sites, featuring flexible flo

    2/11/26 12:30:00 PM ET
    $TOL
    Homebuilding
    Consumer Discretionary

    Toll Brothers Announces New Luxury Home Community Coming Soon to Nolensville, Tennessee

    NOLENSVILLE, Tenn., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced its newest Nashville-area community, Sagebrook by Toll Brothers, is coming soon to Nolensville, Tennessee. This highly anticipated community will be located on Clovercroft Road and Sagebrook Drive in Nolensville. Site development is underway and the community is anticipated to open for sale in fall 2026.Located less than a mile from historic downtown Nolensville, Sagebrook by Toll Brothers will feature 26 exquisite single-family homes. The all-new floor plans will include 4 to 5 spacious bedrooms and offer up to 4,883 square feet of elegant liv

    2/10/26 11:57:20 AM ET
    $TOL
    Homebuilding
    Consumer Discretionary

    James D. Farley, Jr. Elected to McDonald's Board of Directors

    CHICAGO, Feb. 10, 2026 /PRNewswire/ -- McDonald's Corporation (NYSE:MCD) today announced the election of James D. Farley, Jr., to its Board of Directors, effective February 4, 2026.  Mr. Farley currently serves as President and CEO of Ford Motor Company and sits on Ford's Board of Directors, where he is guiding the company's Ford+ transformation, a strategy centered on digital innovation, customer-centric design, and operational modernization. He brings more than 30 years of experience leading complex global organizations and transforming iconic consumer brands. He previously

    2/10/26 9:15:00 AM ET
    $MCD
    Restaurants
    Consumer Discretionary

    $AMR
    $ANET
    $ASAN
    $AVA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Verrica Pharmaceuticals Inc.

    SC 13G/A - Verrica Pharmaceuticals Inc. (0001660334) (Subject)

    12/9/24 6:22:49 PM ET
    $VRCA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Verrica Pharmaceuticals Inc.

    SC 13D/A - Verrica Pharmaceuticals Inc. (0001660334) (Subject)

    11/26/24 4:15:26 PM ET
    $VRCA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Newmark Group Inc.

    SC 13D/A - NEWMARK GROUP, INC. (0001690680) (Subject)

    11/21/24 4:38:54 PM ET
    $NMRK
    Real Estate
    Finance